Picture of Zenas BioPharma logo

ZBIO — Zenas BioPharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Zenas BioPharma shares rise nearly 8% in market debut

Sept 13 (Reuters) - Shares of Bristol-Myers
Squibb-backed Zenas BioPharma  ZBIO.O  rose nearly 8% in their
Nasdaq debut on Friday, in a sign of recovery for the U.S. IPO
market in 2024 after two sub par years.

 (Reporting by Pritam Biswas in Bengaluru; Editing by Janane
Venkatraman)
 ((Pritam.Biswas@thomsonreuters.com;))

Recent news on Zenas BioPharma

See all news